Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03713268 · ClinicalTrials.gov registry record

Intraoperative OCT Guidance of Intraocular Surgery II

A clinical trial of Healthy and Cataract, sponsored by Duke University.

Recruiting
Registry status
262
Enrollment target
1
Study location

NCT03713268: Recruiting study of Healthy and Cataract, sponsored by Duke University.

NCT03713268 is a study of Healthy and Cataract that is actively recruiting participants, run by Duke University. The registered enrollment target is 262 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03713268, a study of Healthy and Cataract, is actively recruiting participants, sponsored by Duke University.

RECRUITING
Registry status
262 participants
Enrollment target
1
Study location

Study Summary

The overall five-year goals of the project are to develop novel technology to provide actionable new information through provision of live volumetric imaging during surgery, improving surgical practice and outcomes. The investigators believe this technology will enable novel ophthalmic and other microsurgeries not possible due to current limitations in surgical visualization.

Primary Outcome

Ability to capture images

Interventions

  • DEVICE Microscope integrated optical coherence tomography

Study Locations (1)

North Carolina

  • Duke University Eye Center - Durham

Trial Details

FieldValue
Enrollment Target 262 participants
Start Date 2018-09-30
Est. Completion 2027-05-31
Duke University

1,725 total trials

What NCT03713268 shows while recruiting

NCT03713268 is an observational study that tracks outcomes without assigning an intervention. The registered 262 participants enrollment target is mid-sized for trials with a published cap, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (60% lower).

The record links to 10 conditions, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Microscope integrated optical coherence tomography is the first listed.

NCT03713268 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT03713268 about?

NCT03713268 is a clinical study titled "Intraoperative OCT Guidance of Intraocular Surgery II". The overall five-year goals of the project are to develop novel technology to provide actionable new information through provision of live volumetric imaging during surgery, improving surgical practice and outcomes. The investigators believe this technology will enable novel ophthalmic and other mic...

What is the current status of trial NCT03713268?

This trial is currently recruiting. The enrollment target is 262 participants. The study started on 2018-09-30. Estimated completion is 2027-05-31.

What conditions does trial NCT03713268 study?

This clinical trial studies the following conditions: Healthy, Cataract, Diabetic Retinopathy, Retinal Disease, Strabismus.

What interventions are being tested in trial NCT03713268?

The interventions under investigation include: Microscope integrated optical coherence tomography (DEVICE).

Who is sponsoring clinical trial NCT03713268?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03713268 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03713268's enrollment target sits among peer trials

262 94th of 1090 higher than 996 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06074380 · 262 participants · Phase 4

    Non Inferiority Trial Investigating Surfactants Administered Via MIST

  • NCT06293703 · 262 participants · NA

    Effect of Limb Length Ratio on Roux-en-Y Gastric Bypass Outcomes (CLIMB II Study)

  • NCT06780137 · 262 participants · Phase 1

    A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)

  • NCT04067336 · 263 participants · Phase 1

    First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03713268, the US trial registry maintained by the National Library of Medicine. NCT03713268 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.